Fenretinide: a novel treatment for endometrial cancer.

Fenretinide: a novel treatment for endometrial cancer.

Resistance to progestin treatment is a major hurdle in the treatment of advanced and reoccurring endometrial cancer. Fenretinide is a synthetic retinoid that has been evaluated in clinical trials as a cancer therapeutic and chemo-preventive agent. Fenretinide has been established to be cytotoxic to...

Full description

Bibliographic Details
Main Authors:	Navdha Mittal, Saurabh Malpani, Matthew Dyson, Masanori Ono, John S Coon, Julie J Kim, Julian C Schink, Serdar E Bulun, Mary Ellen Pavone
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2014-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC4207704?pdf=render

Similar Items

Generation of Progesterone-Responsive Endometrial Stromal Fibroblasts from Human Induced Pluripotent Stem Cells: Role of the WNT/CTNNB1 Pathway
by: Kaoru Miyazaki, et al.
Published: (2018-11-01)

Fenretinide causes emphysema, which is prevented by sphingosine 1-phoshate.
by: Masanori Yasuo, et al.
Published: (2013-01-01)

The protective effect of fenretinide against allergic asthma
by: Kanagaratham Cynthia, et al.
Published: (2010-11-01)

Validated LC-MS/MS Assay for the Quantitative Determination of Fenretinide in Plasma and Tumor and Its Application in a Pharmacokinetic Study in Mice of a Novel Oral Nanoformulation of Fenretinide
by: Cristina Matteo, et al.
Published: (2024-03-01)

Preparation and Characterization of Amorphous Solid Dispersions for the Solubilization of Fenretinide
by: Guendalina Zuccari, et al.
Published: (2023-03-01)

Fenretinide Acts as Potent Radiosensitizer for Treatment of Rhabdomyosarcoma Cells
by: Eva Brack, et al.
Published: (2021-06-01)

Fenretinide: Prevenção em Pacientes Tratadas de Carcinoma de Mama
by: A. Costa, et al.
Published: (2023-08-01)

Pulmonary Delivery of Fenretinide: A Possible Adjuvant Treatment in COVID-19
by: Isabella Orienti, et al.
Published: (2020-05-01)

Retinoids Delivery Systems in Cancer: Liposomal Fenretinide for Neuroectodermal-Derived Tumors
by: Veronica Bensa, et al.
Published: (2021-08-01)

Fenretinide in Cancer and Neurological Disease: A Two-Face Janus Molecule
by: Rosa Luisa Potenza, et al.
Published: (2022-07-01)

Fenretinide Improves Intestinal Barrier Function and Mitigates Alcohol Liver Disease
by: Xiao-Han Tang, et al.
Published: (2021-03-01)

Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastoma
by: Bénard Jean, et al.
Published: (2009-03-01)

A Novel Nanomicellar Combination of Fenretinide and Lenalidomide Shows Marked Antitumor Activity in a Neuroblastoma Xenograft Model
by: Orienti I, et al.
Published: (2019-12-01)

Heterogeneous role of the glutathione antioxidant system in modulating the response of ESFT to fenretinide in normoxia and hypoxia.
by: Tapiwanashe Magwere, et al.
Published: (2011-01-01)

Fenretinide inhibited de novo ceramide synthesis and proinflammatory cytokines induced by Aggregatibacter actinomycetemcomitans
by: Hong Yu, et al.
Published: (2013-01-01)

Cold Physical Plasma-Mediated Fenretinide Prodrug Activation Confers Additive Cytotoxicity in Epithelial Cells
by: Mohsen Ahmadi, et al.
Published: (2023-06-01)

Pretreatment of human retinal pigment epithelial cells with sterculic acid forestalls fenretinide-induced apoptosis
by: Samuel William, et al.
Published: (2022-12-01)

Targeting macrophagic 17β-HSD7 by fenretinide for the treatment of nonalcoholic fatty liver disease
by: Xiaoyu Dong, et al.
Published: (2023-01-01)

Fenretinide-induced apoptosis of Huh-7 hepatocellular carcinoma is retinoic acid receptor β dependent
by: Wan Yu-Jui, et al.
Published: (2007-12-01)

A novel oral micellar fenretinide formulation with enhanced bioavailability and antitumour activity against multiple tumours from cancer stem cells
by: Isabella Orienti, et al.
Published: (2019-08-01)

Cell-based small-molecule compound screen identifies fenretinide as potential therapeutic for translocation-positive rhabdomyosarcoma.
by: David Herrero Martín, et al.
Published: (2013-01-01)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
by: Kim Kyu Kwang, et al.
Published: (2012-04-01)

Fenretinide inhibits obesity and fatty liver disease but induces Smpd3 to increase serum ceramides and worsen atherosclerosis in LDLR−/− mice
by: Dawn Thompson, et al.
Published: (2023-03-01)

Induction of apoptosis by fenretinide in tumor cell lines correlates with DLX2, DLX3 and DLX4 gene expression.
by: Ferrari, N, et al.
Published: (2003)

Inhibitory effects of fenretinide metabolites N-[4-methoxyphenyl]retinamide (MPR) and 4-oxo-N-(4-hydroxyphenyl)retinamide (3-keto-HPR) on fenretinide molecular targets β-carotene oxygenase 1, stearoyl-CoA desaturase 1 and dihydroceramide Δ4-desaturase 1.
by: Eugenia Poliakov, et al.
Published: (2017-01-01)

Converting redox signaling to apoptotic activities by stress-responsive regulators HSF1 and NRF2 in fenretinide treated cancer cells.
by: Kankan Wang, et al.
Published: (2009-10-01)

Fenretinide inhibits macrophage inflammatory mediators and controls hypertension in spontaneously hypertensive rats via the peroxisome proliferator-activated receptor gamma pathway
by: Lin CH, et al.
Published: (2016-11-01)

Brg-1 mediates the constitutive and fenretinide-induced expression of SPARC in mammary carcinoma cells via its interaction with transcription factor Sp1
by: Marco Sergio, et al.
Published: (2010-08-01)

Concurrent endometrial intraepithelial carcinoma (EIC) and endometrial hyperplasia
by: Steven Wang, MD, et al.
Published: (2015-03-01)

Stem cell-like properties of the endometrial side population: implication in endometrial regeneration.
by: Hirotaka Masuda, et al.
Published: (2010-01-01)

Genome-wide progesterone receptor binding: cell type-specific and shared mechanisms in T47D breast cancer cells and primary leiomyoma cells.
by: Ping Yin, et al.
Published: (2012-01-01)

The Diagnostic Accuracy of Endometrial Sampling in Endometrial Hyperplasia
by: Serdar Başaranoğlu, et al.
Published: (2017-04-01)

Establishment of human patient-derived endometrial cancer xenografts in NOD scid gamma mice for the study of invasion and metastasis.
by: Kenji Unno, et al.
Published: (2014-01-01)

A novel promoter controls Cyp19a1 gene expression in mouse adipose tissue
by: Lin Zhihong, et al.
Published: (2009-04-01)

Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis
by: Matthew Brown, et al.
Published: (2023-10-01)

An Overview of Endometrial Cancer with Novel Therapeutic Strategies
by: Theresa M. Kuhn, et al.
Published: (2023-08-01)

Novel Insights into Molecular Mechanisms of Endometrial Diseases
by: Tullio Golia D’Augè, et al.
Published: (2023-03-01)

Novel promising biomarkers in endometrial cancer - review
by: Dominika Krawczyk, et al.
Published: (2019-08-01)

An estrogen-sensitive fibroblast population drives abdominal muscle fibrosis in an inguinal hernia mouse model
by: Tanvi Potluri, et al.
Published: (2022-05-01)

Turkish Adaptation and Reliability and Validity Study of Parent Attitudes About Childhood Vaccines Survey
by: Mehtap Ataseven Bulun, et al.
Published: (2020-12-01)